|
| |
Biotec Pharmacon ASA Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - Biotec Pharmacon ASA - Profile
Biotec Pharmacon ASA. View the current Biotec Pharmacon ASA Page on BioPortfolio .com ... Pharma Live: Nov 22 2008 5:55AM Matching: biotec pharmacon asa ...
http://www.bioportfolio.com/biocorporate/1896-Biotec%2BPharm...
|
Board of Directors - Algeta
He is Chairman of the Board of Biotec Pharmacon ASA and holds several other board positions in early stage companies, mainly in the life science sector. ...
http://www.algeta.com/default.asp?menuID=3817&smenuID=4298...
|
BioPortfolio - Biotec Pharmacon ASA - Profile
View the current Biotec Pharmacon ASA Page on BioPortfolio.com ... Dr. Sven Rohmann (46) joins Biotec Pharmacon ASA as Vice President Business Development
...
http://www.bioportfolio.com/biocorporate/1896-Biotec%252BPha...
|
Oral administration of a new soluble branched β-1,3-D-glucan is ...
The study was sponsored by Biotec Pharmacon ASA, Tromsø, Norway, and monitored by Mericon AS, Skien, Norway. The authors are indebted to Eva Vognild at ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=18...
|
BioPortfolio - Biotec Pharmacon - Profile
biology grade enzymes, based on own research in immunology and marine biotechnology. BioNews Results for Biotec Pharmacon. • Biotec Pharmacon ASA (NO)
...
http://www.bioportfolio.com/biocorporate/19840-Biotec%252525...
|
BioWorld International
Biotec Pharmacon ASA, of Tromsø, Norway, will initiate a clinical trial in the first half of 2006 of its formulation of soluble beta glucan (SBG) in ...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...
|
BioPortfolio - Biocorporate Search biotechnology
Biotec Pharmacon ASA. Biotec Pharmacon develops, manufactures, and markets immune modulating compounds and molecular biology grade enzymes, ...
http://www.bioportfolio.com/biocorporate/search.php?page=8&q...
|
Oral and systemic administration of β-glucan protects against ...
Endotoxin free (< 0·5 EU/ml) SBG, a S. cerevisiae-derived water-soluble β-1,3/1, 6-glucan was provided by Biotec Pharmacon ASA (Tromsø, Norway). ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=18...
|
BioPortfolio - Miltenyi Biotec - Profile
BioNews Results for Miltenyi Biotec. • Biotec Pharmacon ASA (NO) - Phase III Program Continues as Planned After Interim Analysis ...
http://www.bioportfolio.com/biocorporate/7118-Miltenyi+Biote...
|
Orphan Drug Approvals: Pegylated Arginine Deiminase, Beta-1,3/1,6 ...
1 Aug 2005 ... On June 16, the European Commission approved orphan drug status for soluble yeast beta-1,3/1,6-glucan (made by Biotec Pharmacon ASA) for ...
http://www.medscape.com/viewarticle/509844...
|
|
